Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Drug Development
New findings from DNAPrint Genomics, Inc. in the area of drug development published
April 19th, 2008
A report, 'DNAPrint Genomics, Inc.: better drugs for segmented markets,' is newly published data in Pharmacogenomics. "The postgenome era promises more efficient drug-development cycles and medications targeted to compatible populations, resulting in improved outcomes, fewer drug-company failures, less litigation, fewer recalls and a refurbished image of 'pharma' in the mind of the customer. DNAPrint was founded to help precipitate these changes," scientists writing in the journal Pharmacogenomics report. "Since 1999, we have developed and optimized novel methods for assessing patient response proclivities as individuals but also as constituents of...
Source: Law & Health Weekly (2008-04-19)
|
